Healthcare
GSK launches $50m venture capital fund
GlaxoSmithKline (GSK) has launched a $50m strategic venture capital fund, Action Potential Venture Capital (APVC), to make investments in the biotech and bioelectric medicines industries.
BayBG invests in puracon
Bayerische Beteiligungsgesellschaft (BayBG) has bought a minority stake in puracon, a supplier of packaging for medical products.
Caledonia buys Choice Care from Sovereign
Caledonia Investments has acquired UK–based Choice Care Homes from Sovereign Capital for £86m.
Graphite Capital exits Willowbrook
Graphite Capital has sold its majority stake in Willowbrook Healthcare, an owner of care homes for the elderly, to the company's management.
VC-backed Profibrix sold to big pharma
Index Ventures, Gilde Healthcare Partners, Vesalius Biocapital and Inkef Capital have sold Dutch biotech firm Profibrix to The Medicines Company for a total consideration of $240m.
HTGF backs exelonix in seed round
High-Tech Gründerfonds (HTGF) has provided seed funding to exelonix, a provider of internet-based assistance systems for elderly people.
HTGF's CorTec receives €3m series-A funding
KfW Banking Group and seed investor M-Invest have injected €3m into High-Tech Gründerfonds (HTGF) portfolio company CorTec.
BaltCap offloads Medicap to synlab
Baltic-focused private equity firm BaltCap has sold Medicap Holding to European laboratory services provider synlab.
HTGF backs NovaPump in series-A funding
High-Tech Gründerfonds has invested in medical company NovaPump as part of a series-A funding round.
Waterland sells SLG to Medica
Waterland Private Equity Investments has wholly divested its Belgian portfolio company Senior Living Group (SLG) to Medica, a France-based dependency care provider.
HTGF's Capical receives series-A funding
KfW and M-Invest have invested in Capical, a medical technology company backed by High-Tech Gründerfonds (HTGF), in a series-A funding round.
Imperial et al. back Polytherics and Antitope merger
Imperial Innovations, Mercia Fund Management, Catapult Venture Managers and Invesco Perpetual have provided £13.5m for the takeover of Antitope by UK-based biotechnology firm Polytherics.
Xanit bolts on Croasa
Xanit International Hospital, the healthcare provider backed by N+1 Mercapital and Partners Group, has completed the bolt-on of oncology centre Croasa.
Atlas leads €2.5m round for Harbour Antibodies
Atlas Venture has led a €2.5m funding round for Rotterdam-based Harbour Antibodies, an engineer of transgenic mice designed to produce high-affinity human antibodies.
Gimv et al. back Jenavalve
A consortium of venture capital investors has injected $62.5m as part of a series-C round for Jenavalve Technology, a Germany-based medical devices manufacturer.
ReNeuron raises £33.2m
Several venture capital investors, including the Wales Life Sciences Investment Fund, have participated in a £33.2m funding round for stem cell development firm ReNeuron.
Absynth Biologics raises £850,000
The North West Fund for Biomedical and Fusion IP have participated in a £850,000 round for vaccination firm Absynth Biologics.
UI Gestion injects €15m into GBNA
French GP UI Gestion has provided private healthcare group GBNA with €15m of growth capital funding.
Idinvest et al. back Pathoquest with €3.8m
Idinvest Partners and Aurinvest, as well as existing backer Kurma Life Sciences Partners (KLS), have injected €3.8m into Paris-based biotechnology firm Pathoquest.
Sentica exits 9lives
Sentica Partners has sold Helsinki-based ambulance and emergency care services company 9lives back to the company’s management.
EdRip in CHF 18m OncoEthix series-B round
Edmond de Rothschild Investment Partners (EdRip) has participated in a series-B funding round totalling CHF 18m for Swiss oncology drug development firm OncoEthix.
Clave Mayor divests Gadea
Spanish venture capital investor Clave Mayor has divested its 9.73% stake in pharmaceuticals company Gadea Grupo Farmacéutico.
Sovereign supports Eden’s HASS acquisition
Eden Supported Living, backed by buy-and-build specialist Sovereign Capital, has acquired Housing & Support Solutions (HASS).
Synova-backed Clearwater in bolt-on
Specialist care provider Clearwater Care, a portfolio company of Synova Capital, has acquired TL Care, a UK-based supported-living provider.